[The effect of pre- @entity1188 unstable @entity951 on the size of XXXX ].

@entity1 @entity296 @entity4136 @entity1459 @entity951 @entity1188 @entity583
INTRODUCTION AND OBJECTIVES: Recent studies suggest that @entity1459 ( @entity1459 ) might induce less @entity296 . The objective of this study is to evaluate whether @entity1 with @entity1459 have smaller @entity583 . METHODS: @entity1 with @entity583 of less than 12 hours since the onset symptoms were included. @entity1459 was defined as unstable @entity951 at rest during the 7 days before the @entity1188 . @entity1188 size was assessed with the area under the curve of CK-MB levels in the 24 hours following the onset of the @entity1188 . RESULTS: One hundred-seventy nine @entity1 were included, 75 (41.9%) with @entity1459 . There were more @entity1 in the group with @entity1459 (89.3% vs 70.2%, p = 0.004) and a higher prevalence of ex-smokers (38.7% vs 19.2%, p = 0.006). We did not find significant differences in @entity583 size between both groups, but a statistically significant interaction between @entity1459 and pre-treatment with @entity4136 drugs was noted (p = 0.050). CONCLUSIONS: @entity1459 does not seem to induce less @entity296 in this study. There is a significant interaction between @entity1459 and pre-treatment with @entity4136 drugs.
